Contactin-2, a synaptic and axonal protein, is reduced in cerebrospinal fluid and brain tissue in Alzheimer’s disease

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1758-9193

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Contactin-2, a synaptic and axonal protein, is reduced in cerebrospinal fluid and brain tissue in Alzheimer’s disease ; volume:10 ; number:1 ; day:1 ; month:6 ; year:2018 ; pages:1-11 ; date:12.2018
Alzheimer's research & therapy ; 10, Heft 1 (1.6.2018), 1-11, 12.2018

Creator: Chatterjee, Madhurima

Contributor: Del Campo, Marta
Morrema, Tjado H. J.
de Waal, Matthijs
van der Flier, Wiesje M.
Hoozemans, Jeroen J. M.
Teunissen, Charlotte E.
SpringerLink (Online service)

DOI: 10.1186/s13195-018-0383-x

URN: urn:nbn:de:101:1-2018081008090507277261

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:34 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Chatterjee, Madhurima
Del Campo, Marta
Morrema, Tjado H. J.
de Waal, Matthijs
van der Flier, Wiesje M.
Hoozemans, Jeroen J. M.
Teunissen, Charlotte E.
SpringerLink (Online service)

Other Objects (12)

Role of BACE1 in Alzheimer’s synaptic function

Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer’s disease continuum

High plasticity of axonal pathology in Alzheimer’s disease mouse models

PLD3 affects axonal spheroids and network defects in Alzheimer’s disease

Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease

Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease

Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease

Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression

Microvesicles from cerebrospinal fluid of patients with Alzheimer’s disease display reduced concentrations of tau and APP protein

Correction to: Alzheimer’s genetic risk factor FERMT2 (Kindlin-2) controls axonal growth and synaptic plasticity in an APP-dependent manner

Alzheimer's disease: synaptic dysfunction and Aβ

Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease

Role of BACE1 in Alzheimer’s synaptic function

Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer’s disease continuum

High plasticity of axonal pathology in Alzheimer’s disease mouse models

PLD3 affects axonal spheroids and network defects in Alzheimer’s disease

Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease

Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease

Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease

Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression

Microvesicles from cerebrospinal fluid of patients with Alzheimer’s disease display reduced concentrations of tau and APP protein

Correction to: Alzheimer’s genetic risk factor FERMT2 (Kindlin-2) controls axonal growth and synaptic plasticity in an APP-dependent manner

Alzheimer's disease: synaptic dysfunction and Aβ

Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease

Role of BACE1 in Alzheimer’s synaptic function

Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer’s disease continuum

High plasticity of axonal pathology in Alzheimer’s disease mouse models

PLD3 affects axonal spheroids and network defects in Alzheimer’s disease

Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease

Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease

Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease

Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression

Microvesicles from cerebrospinal fluid of patients with Alzheimer’s disease display reduced concentrations of tau and APP protein

Correction to: Alzheimer’s genetic risk factor FERMT2 (Kindlin-2) controls axonal growth and synaptic plasticity in an APP-dependent manner

Alzheimer's disease: synaptic dysfunction and Aβ

Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Contactin-2, a synaptic and axonal protein, is reduced in cerebrospinal fluid and brain tissue in Alzheimer’s disease

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Role of BACE1 in Alzheimer’s synaptic function

Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer’s disease continuum

High plasticity of axonal pathology in Alzheimer’s disease mouse models

PLD3 affects axonal spheroids and network defects in Alzheimer’s disease

Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease

Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease

Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease

Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression

Microvesicles from cerebrospinal fluid of patients with Alzheimer’s disease display reduced concentrations of tau and APP protein

Correction to: Alzheimer’s genetic risk factor FERMT2 (Kindlin-2) controls axonal growth and synaptic plasticity in an APP-dependent manner

Alzheimer's disease: synaptic dysfunction and Aβ

Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease

Role of BACE1 in Alzheimer’s synaptic function

Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer’s disease continuum

High plasticity of axonal pathology in Alzheimer’s disease mouse models

PLD3 affects axonal spheroids and network defects in Alzheimer’s disease

Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease

Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease

Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease

Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression

Microvesicles from cerebrospinal fluid of patients with Alzheimer’s disease display reduced concentrations of tau and APP protein

Correction to: Alzheimer’s genetic risk factor FERMT2 (Kindlin-2) controls axonal growth and synaptic plasticity in an APP-dependent manner

Alzheimer's disease: synaptic dysfunction and Aβ

Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease

Role of BACE1 in Alzheimer’s synaptic function

Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer’s disease continuum

High plasticity of axonal pathology in Alzheimer’s disease mouse models

PLD3 affects axonal spheroids and network defects in Alzheimer’s disease

Oligomeric Aβ-induced synaptic dysfunction in Alzheimer’s disease

Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease

Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease

Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression

Microvesicles from cerebrospinal fluid of patients with Alzheimer’s disease display reduced concentrations of tau and APP protein

Correction to: Alzheimer’s genetic risk factor FERMT2 (Kindlin-2) controls axonal growth and synaptic plasticity in an APP-dependent manner

Alzheimer's disease: synaptic dysfunction and Aβ

Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer’s disease

Related objects

Reset password